Episode #391: VO2 Max vs. Cardiorespiratory Fitness, GLP-1 Costs, and the 10,000-Step Myth | Direct Line March 2026 (Free)

Episode #391: VO2 Max vs. Cardiorespiratory Fitness, GLP-1 Costs, and the 10,000-Step Myth | Direct Line March 2026 (Free)

Author: Barbell Medicine March 24, 2026 Duration: 30:34
Barbell Medicine Podcast
HealthHealth & FitnessFitness

In this free preview of the March 2026 Direct Line AMA. Drs. Feigenbaum and Baraki cover: VO2 max versus cardiorespiratory fitness for longevity (are Peter Attia’s targets evidence-based? — with Goodhart’s Law and the JAMA evidence), what GLP-1 medications actually cost now via manufacturer programs ($149–449/month), and whether 7,000–10,000 daily steps actually meet the bar for cardiovascular training.


Full episode for Barbell Medicine Plus subscribers at https://barbellmedicine.supercast.com/


Timestamps:

0:00 — Introduction

3:26 — VO2 Max vs. Cardiorespiratory Fitness for Longevity

14:11 — GLP-1 Costs: What you should actually be paying now

21:43 — Is Walking Enough for Cardiovascular Health?


Next Steps:


For evidence-based resistance training programs: barbellmedicine.com/training-programs


For individualized training consultation: barbellmedicine.com/coaching


Explore our full library of articles on health and performance: barbellmedicine.com/resources


To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com


Resources:


  • JAMA Network Open — Cardiorespiratory Fitness & Long-term Mortality (Mandsager et al.) — Exercise capacity (METs) and longevity — the foundational CRF/mortality study cited in the episode https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707428
  • JAMA — Blair et al. — Physical fitness and all-cause mortality: a prospective study of healthy men and women https://jamanetwork.com/journals/jama/fullarticle/379243
  • Barbell Medicine Vital Five — Multi-modal CRF benchmarks and longevity targets https://www.barbellmedicine.com/vital-5-action-plan/
  • Lilly Direct — Zepbound (tirzepatide) — Manufacturer direct program ($299–449/month) https://www.lillydirect.com/zepbound
  • NovoCare — Wegovy (semaglutide) — Manufacturer savings program ($149–349/month) https://www.novocare.com/patient/medicines/wegovy.html
  • Orforglipron — Eli Lilly oral GLP-1 — What to know about orforglipron (small-molecule oral GLP-1 agonist, pending FDA approval) https://www.lilly.com/news/stories/what-to-know-about-orforglipron


Our Sponsors:
* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com
* Check out Factor: http://factormeals.com/bbm50off
* Check out Quince: https://quince.com/bbm


Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

Hosted by the team at Barbell Medicine, the Barbell Medicine Podcast delves into the complex intersection of health, fitness, and medical science. Rather than offering quick fixes, the discussions here are grounded in evidence-based practice, exploring how training, nutrition, and lifestyle intersect with long-term well-being. You’ll hear nuanced conversations that challenge common fitness myths and provide practical insights applicable to both everyday lifters and clinical populations. Episodes often feature deep dives into rehabilitation, strength programming, pain science, and metabolic health, all delivered with a focus on applying robust scientific principles to real-world scenarios. This podcast serves as a valuable resource for anyone looking to move beyond oversimplified advice and understand the “why” behind effective training and sustainable health practices. Tune in for thoughtful analysis and accessible explanations that make the latest research relevant to your own goals.
Author: Language: English Episodes: 100

Official website RSS
Barbell Medicine Podcast
Podcast Episodes
Direct Line April 2026: Stopping Ozempic and Lifting With Osteopenia [not-audio_url] [/not-audio_url]

Duration: 38:39
Stop a GLP-1 and about two thirds of the weight loss comes back within a year. Three randomized withdrawal trials (SURMOUNT-4, STEP 1 extension, STEP 4) and a new BMJ 2026 systematic review of 37 RCTs and nearly 10,000 a…
Medical Mystery: The Man Who Got Weaker When He Started Training [not-audio_url] [/not-audio_url]

Duration: 1:15:46
A 43-year-old man starts exercising and ends up in the ER with a CK over 100x the upper limit of normal. His doctor says it’s from training. We don’t think so. In this episode, Dr. Jordan Feigenbaum and Dr. Austin Baraki…
Overtraining Syndrome: Causes, Diagnosis, and What's Actually Going On [not-audio_url] [/not-audio_url]

Duration: 1:36:05
In 2022, researchers conducted the most rigorous systematic review ever performed on overtraining syndrome — looking specifically for controlled studies that documented a human transitioning from a healthy training state…
How-To Fix Your Stalled Progress (Strength Edition) [not-audio_url] [/not-audio_url]

Duration: 23:09
Lifting more weight doesn't always mean you've gotten stronger. In this foundational session, Dr. Jordan Feigenbaum and Dr. Austin Baraki introduce the Fitness-Fatigue Model to explain why "stalled" progress is often jus…

12345...10»